- HK$31.47bn
- HK$14.44bn
- CNY8.53bn
- 75
- 40
- 58
- 64
R2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,371 | 5,594 | 6,371 | 7,637 | 8,534 |
Cost of Revenue | |||||
Gross Profit | 3,561 | 4,677 | 5,214 | 6,177 | 7,030 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,608 | 3,632 | 4,318 | 12,275 | 6,376 |
Operating Profit | -237 | 1,963 | 2,053 | -4,638 | 2,158 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -415 | 2,069 | 1,143 | -5,721 | 1,489 |
Provision for Income Taxes | |||||
Net Income After Taxes | -568 | 1,798 | 953 | -5,342 | 1,215 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,546 | 10,045 | 395 | -6,049 | 483 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1,546 | 10,045 | 382 | -6,049 | 458 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.575 | 1.1 | -0.143 | -1.34 | 0.383 |
Dividends per Share |